Structures by: Chidan Kumar C. S.
Total: 70
(2<i>E</i>)-3-(2,4-Dichlorophenyl)-1-(2,5-dichlorothiophen-3-yl)prop-2-en-1-one
C13H6Cl4OS
Acta Crystallographica Section E (2018) 74, 9 1201-1205
a=3.9867(3)Å b=13.4564(11)Å c=25.573(2)Å
α=90° β=90° γ=90°
(2<i>E</i>)-3-(3-Bromo-4-fluorophenyl)-1-(3,4-dimethoxyphenyl)prop-2-en-1-one
C17H14BrFO3
Acta Crystallographica Section E (2018) 74, 8 1063-1066
a=8.9212(12)Å b=8.6601(11)Å c=20.538(3)Å
α=90° β=96.896(3)° γ=90°
1-[2-(Adamantan-1-yl)-2-oxoethyl]pyridin-4-iminium bromide
C17H23N2O,Br
Acta Crystallographica Section E (2018) 74, 7 1030-1034
a=18.758(2)Å b=7.1508(8)Å c=11.9909(14)Å
α=90° β=98.2117(17)° γ=90°
2,2'-Methylenebis(isoindoline-1,3-dione)
C17H10N2O4
Acta Crystallographica Section E (2019) 75, 1 49-52
a=26.296(5)Å b=7.9996(15)Å c=16.987(4)Å
α=90° β=129.165(10)° γ=90°
(<i>E</i>)-3-(4-Fluorophenyl)-1-(4-nitrophenyl)prop-2-en-1-one
C15H10FNO3
Acta Crystallographica Section E (2019) 75, 1 53-57
a=3.8860(5)Å b=13.2324(16)Å c=24.199(3)Å
α=90° β=91.963(2)° γ=90°
2-(1,3-Dioxoindan-2-yl)isoquinoline-1,3,4-trione
C18H9NO5
Acta Crystallographica Section E (2015) 71, 1 o6-o7
a=12.60800(10)Å b=13.6849(2)Å c=8.44670(10)Å
α=90° β=102.0510(10)° γ=90°
3-(Adamantan-1-yl)-4-(4-chlorophenyl)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C18H20ClN3S
Acta Crystallographica Section E (2015) 71, 2 o115-o116
a=23.1302(5)Å b=23.1302(5)Å c=6.4100(2)Å
α=90° β=90° γ=90°
3-[(4-Benzylpiperazin-1-yl)methyl]-5-(thiophen-2-yl)-2,3-dihydro-1,3,4-oxadiazole-2-thione
C18H20N4OS2
Acta Crystallographica Section E (2015) 71, 3 o175-o176
a=10.6909(5)Å b=29.3658(13)Å c=15.6179(6)Å
α=90° β=130.283(2)° γ=90°
(2<i>E</i>)-1-(3-Bromophenyl)-3-(4-fluorophenyl)prop-2-en-1-one
C15H10BrFO
Acta Crystallographica Section E (2019) 75, 2 146-149
a=5.9255(6)Å b=7.5867(8)Å c=14.1427(15)Å
α=89.774(2)° β=82.671(2)° γ=87.712(2)°
(<i>E</i>)-3-(2-chlorophenyl)-1-(2,5-dichlorothiophen-3-yl)prop-2-en-1-one
C13H7Cl3OS
Acta Crystallographica Section E (2019) 75, 2 124-128
a=3.9017(6)Å b=22.038(3)Å c=15.127(2)Å
α=90° β=96.998(3)° γ=90°
(2<i>E</i>)-3-(4-Chloro-3-fluorophenyl)-1-(3,4-dimethoxyphenyl)prop-2-en-1-one
C17H14ClFO3
Acta Crystallographica Section E (2019) 75, 7 942-945
a=14.9088(13)Å b=5.7669(5)Å c=17.9074(15)Å
α=90° β=104.491(2)° γ=90°
(<i>E</i>)-1-(3-bromophenyl)-3-(2,6-dichlorophenyl)prop-2-en-1-one
C15H9BrCl2O
Acta Crystallographica, Section E (2019) 75, 2 264-267
a=3.9834(7)Å b=13.471(2)Å c=25.661(4)Å
α=90° β=92.736(4)° γ=90°
6-Chloro-5-isopropylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C7H9ClN2O2
Acta Crystallographica Section E (2014) 70, 11 o1144-o1145
a=11.2244(4)Å b=6.8288(3)Å c=11.6641(5)Å
α=90.00° β=104.577(2)° γ=90.00°
Cyclohexylammonium thiocyanate
C6H14N,CNS
Acta Crystallographica Section E (2015) 71, 1 o62-o63
a=23.4036(6)Å b=23.4036(6)Å c=8.3373(2)Å
α=90° β=90° γ=120°
2-{[(4-Iminiumyl-3-methyl-1,4-dihydropyridin-1-yl)methyl]carbamoyl}benzoate hemihydrate
C15H15N3O3,0.5(H2O)
Acta Crystallographica, Section E (2017) 73, 7 927-931
a=21.3157(18)Å b=11.9883(8)Å c=22.8642(15)Å
α=90° β=103.729(2)° γ=90°
2-(Adamantan-1-yl)-5-(4-bromophenyl)-1,3,4-oxadiazole
C18H19BrN2O
Acta Crystallographica Section E (2014) 70, 12 o1231-o1232
a=13.2571(5)Å b=6.4753(3)Å c=19.6761(7)Å
α=90.00° β=114.924(2)° γ=90.00°
2-(4-Nitrophenyl)-2-oxoethyl 2-chlorobenzoate
C15H10ClNO5
Acta crystallographica. Section E, Crystallographic communications (2019) 75, Pt 11 1792-1796
a=12.6646(18)Å b=12.4099(18)Å c=9.0902(13)Å
α=90° β=99.947(2)° γ=90°
2-(4-Nitrophenyl)-2-oxoethyl picolinate
C14H10N2O5
Acta crystallographica. Section E, Crystallographic communications (2019) 75, Pt 11 1763-1767
a=4.6292(4)Å b=10.6563(9)Å c=13.3592(11)Å
α=99.1360(10)° β=93.4260(10)° γ=100.5560(10)°
2-(4-Nitrophenyl)-2-oxoethyl benzoate
C15H11NO5
Acta crystallographica. Section E, Crystallographic communications (2019) 75, Pt 11 1719-1723
a=7.3371(4)Å b=21.0051(11)Å c=8.3069(4)Å
α=90° β=102.7110(10)° γ=90°
(<i>E</i>)-3-(2-Chloro-4-fluorophenyl)-1-(2,5-dichlorothiophen-3-yl)prop-2-en-1-one
C13H6Cl3FOS
Acta crystallographica. Section E, Crystallographic communications (2018) 74, Pt 8 1134-1137
a=3.9564(8)Å b=13.367(2)Å c=25.173(5)Å
α=90° β=93.363(4)° γ=90°
(2<i>E</i>)-3-(3-Chlorophenyl)-1-(3,4-dimethoxyphenyl)prop-2-en-1-one
C17H15ClO3
Acta crystallographica. Section E, Crystallographic communications (2018) 74, Pt 7 935-938
a=9.0491(4)Å b=8.3257(4)Å c=20.2857(9)Å
α=90° β=99.4840(10)° γ=90°
(2<i>E</i>,2'<i>E</i>)-3,3'-(1,4-phenylene)bis[1-(4-hydroxyphenyl)prop-2-en-1-one] <i>N</i>,<i>N</i>-dimethylformamide disolvate
C24H18O4,2(C3H7NO)
Acta crystallographica. Section E, Crystallographic communications (2018) 74, Pt 6 835-839
a=6.0569(5)Å b=9.5801(5)Å c=11.9941(8)Å
α=72.867(2)° β=84.649(2)° γ=86.710(2)°
1-[2-([1,1'-Biphenyl]-4-yl)-2-oxoethyl]-3-methyl-1,4-dihydropyridin-4-iminium bromide
C20H19N2O,Br
Acta crystallographica. Section E, Crystallographic communications (2018) 74, Pt 5 752-756
a=15.3991(10)Å b=7.9078(5)Å c=15.7645(10)Å
α=90° β=113.0370(10)° γ=90°
(2<i>E</i>,2'<i>E</i>)-3,3'-(1,4-Phenylene)bis[1-(2,4-difluorophenyl)prop-2-en-1-one]
C24H14F4O2
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 12 1812-1816
a=12.190(6)Å b=5.972(3)Å c=38.17(2)Å
α=90° β=98.013(10)° γ=90°
2-(Benzofuran-2-yl)-2-oxoethyl 2-chlorobenzoate
C17H11ClO4
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 8 1227-1231
a=5.5333(8)Å b=11.3212(17)Å c=11.5186(18)Å
α=92.283(3)° β=91.536(3)° γ=99.638(3)°
2-(1<i>H</i>-1-Benzofuran-2-yl)-2-oxoethyl 2-nitrobenzoate
C17H11NO6
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 7 1087-1091
a=9.3022(10)Å b=28.482(3)Å c=5.5208(6)Å
α=90° β=90° γ=90°
2-(Benzofuran-2-yl)-2-oxoethyl 2-methoxybenzoate
C18H14O5
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 8 1227-1231
a=7.4094(3)Å b=9.7566(4)Å c=10.5832(5)Å
α=83.4300(10)° β=71.8080(10)° γ=87.2650(10)°
2-(1<i>H</i>-1-Benzofuran-2-yl)-2-oxoethyl 2-aminobenzoate
C17H13NO4
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 7 1087-1091
a=5.1839(12)Å b=10.853(3)Å c=12.269(3)Å
α=93.562(3)° β=91.167(3)° γ=98.714(3)°
(2<i>E</i>,2'<i>E</i>)-3,3'-(1,4-Phenylene)bis[1-(2-methoxyphenyl)prop-2-en-1-one]
C26H22O4
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 6 896-900
a=7.1078(11)Å b=24.544(4)Å c=6.0449(9)Å
α=90° β=101.898(2)° γ=90°
(2<i>E</i>,2'<i>E</i>)-3,3'-(1,4-Phenylene)bis[1-(3-methoxyphenyl)prop-2-en-1-one]
C26H22O4
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 6 896-900
a=5.2626(5)Å b=15.6157(14)Å c=12.4824(11)Å
α=90° β=98.760(2)° γ=90°
(2<i>E</i>,2'<i>E</i>)-3,3'-(1,4-Phenylene)bis[1-(3,4-dimethoxyphenyl)prop-2-en-1-one]
C28H26O6
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 6 896-900
a=6.9595(6)Å b=21.0272(17)Å c=8.3297(7)Å
α=90° β=103.602(2)° γ=90°
(4-Bromophenyl)(1<i>H</i>-indol-7-yl)methanone
C15H10BrNO
Acta Crystallographica Section E (2009) 65, 11 o2933
a=11.3241(4)Å b=7.4651(3)Å c=14.9579(5)Å
α=90.00° β=103.100(4)° γ=90.00°
(1<i>E</i>)-1-(3-Bromophenyl)ethanone 2,4-dinitrophenylhydrazone
C14H11BrN4O4
Acta Crystallographica Section E (2010) 66, 11 o2832-o2833
a=7.7546(9)Å b=13.4362(15)Å c=14.1884(16)Å
α=91.894(2)° β=90.553(2)° γ=97.128(2)°
<i>N</i>-[(2-Chloro-3-quinolyl)methyl]-4-fluoroaniline
C16H12ClFN2
Acta Crystallographica Section E (2010) 66, 10 o2548-o2549
a=7.3661(8)Å b=8.8967(9)Å c=11.5129(12)Å
α=68.7040(10)° β=74.4680(10)° γ=75.4450(10)°
Fluconazolium picrate
C13H13F2N6O,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 10 o2568
a=5.6470(10)Å b=17.347(2)Å c=22.571(2)Å
α=90.00° β=94.270(10)° γ=90.00°
1-(2,5-Dichloro-3-thienyl)ethanone
C6H4Cl2OS
Acta Crystallographica Section E (2010) 66, 10 o2480
a=13.0980(3)Å b=7.17900(10)Å c=16.3290(3)Å
α=90.00° β=90.00° γ=90.00°
4,6-Dichloro-5-methoxypyrimidine
C5H4Cl2N2O
Acta Crystallographica Section E (2010) 66, 2 o408
a=13.6545(19)Å b=3.9290(6)Å c=13.0275(18)Å
α=90.00° β=90.00° γ=90.00°
4-(Methylsulfonyl)piperazin-1-ium chloride
C5H13N2O2S,Cl
Acta Crystallographica Section E (2010) 66, 2 o361-o362
a=6.02310(10)Å b=9.1097(2)Å c=7.9852(2)Å
α=90.00° β=100.7000(10)° γ=90.00°
2,4-Dichloro-1-[1-(2,4-dichlorobenzyloxy)ethyl]benzene
C15H12Cl4O
Acta Crystallographica Section E (2010) 66, 1 o165-o166
a=9.3755(4)Å b=9.9229(4)Å c=9.9667(4)Å
α=62.313(3)° β=70.246(4)° γ=71.467(4)°
Cinnarizinium dipicrate
C26H30N22,2(C6H2N3O7)
Acta Crystallographica Section E (2011) 67, 2 o500-o501
a=15.1987(2)Å b=10.09130(17)Å c=25.0724(3)Å
α=90.00° β=95.9170(14)° γ=90.00°
3-Methyl-1,2,4-triazolo[3,4-<i>a</i>]phthalazine monohydrate
C10H8N4,H2O
Acta Crystallographica Section E (2009) 65, 11 o2694
a=7.3009(9)Å b=7.9253(9)Å c=9.2755(10)Å
α=109.663(10)° β=104.910(10)° γ=95.830(9)°
(<i>E</i>)-3-(Biphenyl-4-yl)-1-(3-bromophenyl)prop-2-en-1-one
C21H15BrO
Acta Crystallographica Section E (2009) 65, 11 o2856-o2857
a=6.0920(10)Å b=7.2950(10)Å c=36.619(2)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Chlorophenoxy)acetohydrazide
C8H9ClN2O2
Acta Crystallographica Section E (2009) 65, 12 o3189
a=6.4440(10)Å b=4.0110(10)Å c=35.369(4)Å
α=90.00° β=91.890(10)° γ=90.00°
2-Isopropyl-5-methylcyclohexyl 5-acetoxy-1,3-oxathiolane-2-carboxylate
C16H26O5S
Acta Crystallographica Section E (2009) 65, 12 o3169
a=5.3290(10)Å b=13.8670(10)Å c=23.490(2)Å
α=90.00° β=90.00° γ=90.00°
4-Amino-<i>N</i>-(6-chloro-5-methoxypyrimidin-4-yl)benzenesulfonamide
C11H11ClN4O3S
Acta Crystallographica Section E (2010) 66, 2 o372-o373
a=12.8792(6)Å b=13.3557(6)Å c=8.0867(4)Å
α=90.00° β=102.3960(10)° γ=90.00°
3-(3-Bromo-4-methoxyphenyl)-1,5-diphenylpentane-1,5-dione
C24H21BrO3
Acta Crystallographica Section E (2010) 66, 4 o816
a=12.7305(4)Å b=7.14024(19)Å c=22.8133(8)Å
α=90.00° β=105.602(3)° γ=90.00°
(<i>E</i>)-1-(2,5-Dichloro-3-thienyl)-3-[4-(dimethylamino)phenyl]prop-2-en-1-one
C15H13Cl2NOS
Acta Crystallographica Section E (2010) 66, 5 o1139
a=7.2637(9)Å b=8.1136(9)Å c=13.478(2)Å
α=89.011(9)° β=79.710(10)° γ=73.070(10)°
(2<i>E</i>)-1-(2,5-Dichloro-3-thienyl)-3-(6-methoxy-2-naphthyl)prop-2-en-1-one
C18H12Cl2O2S
Acta Crystallographica Section E (2010) 66, 7 o1717
a=7.3237(5)Å b=9.4919(6)Å c=22.4037(15)Å
α=90.00° β=96.1830(10)° γ=90.00°
(2<i>E</i>)-1-(3-Bromophenyl)-3-(4,5-dimethoxy-2-nitrophenyl)prop-2-en-1-one
C17H14BrNO5
Acta Crystallographica Section E (2010) 66, 11 o2936-o2937
a=6.8547(2)Å b=8.3205(2)Å c=27.1509(6)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-1-(2,5-Dichloro-3-thienyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one
C15H12Cl2O3S
Acta Crystallographica Section E (2010) 66, 10 o2479
a=8.9331(2)Å b=8.9997(2)Å c=18.8210(5)Å
α=90.00° β=100.1810(10)° γ=90.00°
(2<i>E</i>)-3-(1,3-Benzodioxol-5-yl)-1-(3-bromo-2-thienyl)prop-2-en-1-one
C14H9BrO3S
Acta Crystallographica Section E (2010) 66, 10 o2477
a=4.0013(3)Å b=11.0211(9)Å c=14.6931(11)Å
α=90.00° β=95.781(2)° γ=90.00°
Cinnarizinium picrate
C26H29N2,C6H2N3O7
Acta Crystallographica Section E (2012) 68, 6 o1747
a=14.5906(19)Å b=12.7720(17)Å c=16.441(2)Å
α=90.00° β=103.114(2)° γ=90.00°
Methyl 3-[(6-nitro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)sulfanyl]propanoate
C18H15N3O5S
Acta Crystallographica Section E (2013) 69, 7 o1111
a=4.9146(3)Å b=26.5065(18)Å c=14.0900(9)Å
α=90.00° β=94.645(4)° γ=90.00°
3-(Adamantan-1-yl)-4-benzyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C19H23N3S
Acta Crystallographica Section E (2014) 70, 7 o766-o767
a=7.6407(4)Å b=10.5150(5)Å c=12.3434(5)Å
α=67.1806(13)° β=72.9688(13)° γ=70.0695(14)°
(<i>E</i>)-1-(2,4-Dinitrophenyl)-2-(2-fluorobenzylidene)hydrazine
C13H9FN4O4
Acta Crystallographica Section E (2011) 67, 5 o1200-o1201
a=7.0961(8)Å b=8.2714(9)Å c=11.7230(8)Å
α=88.614(7)° β=80.544(8)° γ=71.368(10)°
1-(2,4-Dinitrophenyl)-2-[(<i>E</i>)-(3,4,5-trimethoxybenzylidene)]hydrazine
C16H16N4O7
Acta Crystallographica Section E (2014) 70, 2 o188-o189
a=7.4724(4)Å b=14.3106(7)Å c=16.1549(7)Å
α=90.00° β=90.00° γ=90.00°
5-Propyl-6-(<i>p</i>-tolylsulfanyl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C14H16N2O2S
Acta Crystallographica Section E (2014) 70, 2 o179-o180
a=11.8356(3)Å b=10.3040(2)Å c=13.3999(3)Å
α=90.00° β=119.850(2)° γ=90.00°
6-[(2-Methylphenyl)sulfanyl]-5-propylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C14H16N2O2S
Acta Crystallographica Section E (2014) 70, 7 o768-o769
a=10.3434(8)Å b=5.3355(3)Å c=24.4948(18)Å
α=90.00° β=91.171(3)° γ=90.00°
(1<i>E</i>,2<i>E</i>)-1,2-Bis(3-bromo-4-methoxybenzylidene)hydrazine
C16H14Br2N2O2
Acta Crystallographica Section E (2011) 67, 6 o1379
a=10.1354(8)Å b=10.5500(10)Å c=15.6055(12)Å
α=90.00° β=96.680(7)° γ=90.00°
4-[(4-Chlorophenyl)(phenyl)methyl]piperazin-1-ium picrate monohydrate
C17H20ClN2,C6H2N3O7,H2O
Acta Crystallographica Section E (2012) 68, 8 o2486
a=21.144(2)Å b=8.2997(8)Å c=28.528(3)Å
α=90.00° β=93.0290(10)° γ=90.00°
1-[(4-Chlorophenyl)(phenyl)methyl]piperazine-1,4-diium bis(trichloroacetate)-- trichloroacetic acid (1/1)
C17H21ClN22,2(C2Cl3O2),C2HCl3O2
Acta Crystallographica Section E (2012) 68, 9 o2695-o2696
a=9.746(2)Å b=13.096(3)Å c=13.725(3)Å
α=88.317(3)° β=73.127(3)° γ=77.169(3)°
2-Amino-6-methyl-5-{5-[(naphthalen-2-yloxy)methyl]-1,3,4-oxadiazol-2-ylsulfanyl}-4-(3-nitrophenyl)pyridine-3-carbonitrile
C26H18N6O4S
Acta Crystallographica Section E (2013) 69, 4 o491-o492
a=9.6132(9)Å b=9.8928(10)Å c=25.724(2)Å
α=83.215(2)° β=84.102(2)° γ=72.564(2)°
3-(Adamantan-1-yl)-4-ethyl-1-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C26H37N5OS
Acta Crystallographica Section E (2014) 70, 1 o25-o26
a=19.8170(3)Å b=11.9384(3)Å c=21.7807(4)Å
α=90.00° β=107.886(2)° γ=90.00°
(<i>E</i>)-1-(2,4-Dinitrophenyl)-2-(3-ethoxy-4-hydroxybenzylidene)hydrazine
C15H14N4O6
Acta Crystallographica Section E (2014) 70, 1 o89-o90
a=10.245(4)Å b=13.679(5)Å c=14.184(5)Å
α=90.00° β=129.15(2)° γ=90.00°
3-(4-Aminophenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1<i>H</i>-pyrazole-1-carbothioamide
C17H18N4OS
Acta Crystallographica Section E (2013) 69, 8 o1227-o1228
a=8.0052(2)Å b=17.3439(5)Å c=12.4588(3)Å
α=90.00° β=114.7890(10)° γ=90.00°
<i>N</i>-(4-Acetylphenyl)-4-methoxybenzenesulfonamide
C15H15NO4S
Acta Crystallographica Section E (2013) 69, 12 o1750-o1751
a=12.8220(3)Å b=8.2709(2)Å c=14.6165(4)Å
α=90.00° β=112.8410(10)° γ=90.00°
3-(Adamantan-1-yl)-1-[(4-benzylpiperazin-1-yl)methyl]-4-ethyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C26H37N5S
Acta Crystallographica Section E (2013) 69, 12 o1813-o1814
a=10.5618(2)Å b=11.2123(2)Å c=11.3084(2)Å
α=89.9740(10)° β=77.6190(10)° γ=70.8420(10)°
<i>N</i>-(Adamantan-1-yl)-1,2,3,4-tetrahydroisoquinoline-2-carbothioamide
C20H26N2S
Acta Crystallographica Section E (2013) 69, 12 o1815
a=19.1707(5)Å b=6.4106(2)Å c=14.2838(3)Å
α=90.00° β=103.366(2)° γ=90.00°
4-(2-Methoxyphenyl)piperazin-1-ium 6-chloro-5-isopropyl-2,4-dioxopyrimidin-1-ide
C11H17N2O,C7H8ClN2O2
Acta Crystallographica Section E (2014) 70, 3 o245-o246
a=8.9416(2)Å b=10.5152(3)Å c=20.5626(5)Å
α=90.00° β=98.8320(10)° γ=90.00°
Cyclohexylammonium nitrate
C6H14N1,NO3
Acta Crystallographica Section E (2014) 70, 3 o253-o254
a=8.9322(9)Å b=9.9010(9)Å c=10.3951(10)Å
α=90.00° β=103.866(2)° γ=90.00°